Elevated levels of Lipoprotein (a) levels may be used as tool to monitor Diabetic Kidney disease

Written By :  Dr.Niharika Harsha B
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-01-11 04:30 GMT   |   Update On 2023-01-11 07:47 GMT
Advertisement

People's Republic of China: Researchers from China found that elevated levels of lipoprotein (a) can be used as a tool to monitor Diabetic Kidney disease as it is associated with decreased GFR, increased proteinuria, and renal pathological progression. The study results were published in the Journal of Diabetes and its Complications. 

Diabetic kidney disease (DKD) is a major complication of diabetes and is the leading cause of the end-stage renal disease (ESRD) thus affecting the quality of life of patients. Other contributing factors for renal insufficiency are hypertension, dyslipidemia, obesity, renal vascular diseases, acute kidney injury, etc. Dyslipidemia is common in diabetes mellitus, and its role in the pathogenesis of DKD is not clearly understood. Due to the scarcity of data currently on the role of lipid metabolism in diabetic kidney disease (DKD), Anni Wang and the team from the People's Republic of China conducted a study to investigate the correlation between lipid metabolism and renal function as well as renal pathological grade/score in DKD patients. 

Advertisement

Out of 224 patients who were diagnosed with DKD by pathological examination and were retrospectively analyzed, 74 patients were further evaluated by DKD pathological grade/score. Serum lipoprotein (a) [Lp (a)] levels in DKD patients with different chronic kidney disease (CKD) stages was investigated by ANOVA. The relationship between Lp (a) and renal function-related indicators and the DKD pathological grade/score was evaluated by Spearman correlation analysis. The value of Lp (a) in assessing renal function and pathological changes were analyzed by the receiver operating characteristic (ROC) curve. 

Results

  • Different stages of CKD showed significant differences in Lp (a) levels (H = 17.063, p = 0.002) and glomerular grades (H = 12.965, p = 0.005).
  • The various levels with which Lp (a) levels correlated were serum creatinine, blood urea nitrogen, estimated glomerular filtration rate, 24-h proteinuria, urine microalbumin, urine albumin creatinine ratio, glomerular basement membrane thickness, and glomerular grade.
  • ROC curve demonstrated good performance of Lp (a) as an indicator to assess CKD stage 4–5, 24hUPro > 3.5 g, and glomerular grade III-IV. 

Thus, elevated levels of lipoprotein (a) can be used as an indicator of DKD. 

Further reading: Wang A, Zhang S, Li Y, Zhu F, Xie B. Study on the relationship between lipoprotein (a) and diabetic kidney disease. Journal of Diabetes and its Complications. 2023;37(1):108378. doi: 10.1016/j.jdiacomp.2022.108378

Tags:    
Article Source : Journal of Diabetes and its Complications

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News